The Effect of The Walking Exercise Training Given According to Transtheoretical Model, and Follow-Up on Improving Exercise Behavior and Metabolic Control in Type 2 Diabetic Patients
24. april 2018 opdateret af: Emine KAPLAN SERIN, Emine Kaplan Serin
OBJECTIVE This study aims to find out the effects of walking exercise training, which is given according to Transtheoretical Model (TTM), and follow-up on improving exercise behavior and metabolic control in type 2 diabetic patients.
RESEARCH DESIGN AND METHODS The study was conducted as a pre-test, post-test experimental model with 76 intervention (INT) groups and 76 control (CON) groups adult type 2 diabetic patients providing the criteria of the study and followed-up by the diabetes polyclinic of Adıyaman Education and Research Hospital. Patient introduction form (PIF), TTM scales and pedometer were used to collect the data. TTM based training was given to the intervention group according to the patients' change stages at hospital 10 weeks once per every 2 weeks. PIF, TTM scales were applied after the training. PIF, TTM scales were applied to the groups 9 months after the pre-test again.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
152
Fase
- Ikke anvendelig
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 65 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Patients who were diagnosed with type-2 diabetes at least six months before, received basic diabetes information, received insulin and/or oral antidiabetic treatment, whose arterial blood pressure was in systolic ≤ 160 mmHg and diastolic ≤ 100 mmHg, who had HbA1c 7% and over, who were literate and had no communication problems were included in the study.
Exclusion Criteria:
- Those who had developed diabetes-related complications (advanced), were pregnant, diagnosed with cancer, had physical and mental problems that prevent walking were excluded from the study.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Intervention
|
Andre navne:
|
|
Ingen indgriben: Styring
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Patient Presentation Form
Tidsramme: baseline collected
|
The patient presentation form includes questions that question the sociodemographic characteristics and habits of patients, their knowledge of diabetes and its treatment, their exercise status
|
baseline collected
|
|
questions that evaluate the metabolic control variables.
Tidsramme: Change from Baseline at 9 months
|
FBS, SBS, total cholesterol, HbA1c, LDL, triglyceride, diastolic and systolic BP
|
Change from Baseline at 9 months
|
|
Stages of Change for Exercise Questionnaire
Tidsramme: Change from Baseline at 9 months
|
It was developed by Prochaska and DiClemente, adapted by Marcus et al. to exercise.
It was adapted to Turkish society by Ay and Temel in 2007.
The scale consists of five questions and reveals the stage of change where the individual in (pre-thinking, thinking, preparation, taking action and maintenance).
|
Change from Baseline at 9 months
|
|
Exercise Processes of Change Scale
Tidsramme: Change from Baseline at 9 months
|
It was developed by Marcus et al. and adapted to Turkish society by Ay and Temel.
Exercise Processes of Change Scale is based on a 5-point Likert type and consists of 28 items.
The maximum score that an individual can get on the scale is 140, the minimum score is 28.
The scale consists of 10 sub-dimensions and 2 main processes (behavioral process and cognitive process) facilitating change involving these sub-dimensions.
Cognitive processes are increased awareness, dramatic help, environmental reassessment, self-reassessment, social independence.
Behavioral processes are opposition, helping relationships, empowerment management, self-emancipation and stimulus control.
The higher scale scores indicate the higher chance of success of the change.
|
Change from Baseline at 9 months
|
|
Exercise Self-Efficacy Scale
Tidsramme: Change from Baseline at 9 months
|
It was developed by Marcus et al. and adapted to Turkish society by Ay and Temel.
The scale consists of six items, in the form of five-point Likert.
The maximum score that can be taken from the scale is 30 and the minimum score is 6.
In the general evaluation of the scale, according to the general average composed of item score averages, the self-efficacy of high-value-average subjects is high, and the self-efficacy of subjects below the average is considered to be low.
|
Change from Baseline at 9 months
|
|
Exercise Decisional Balance Scale
Tidsramme: Change from Baseline at 9 months
|
It was developed by Marcus et al. and adapted to Turkish society by Ay and Temel.
There are two sub-dimensions that assess subjective perception including perceived benefits of exercise practice and perceived harmfulness of exercise.
The scale is based on 5 point Likert type and consists of 10 items.
The overall score of the scale is formed by subtracting the total score of the perceived harmfulness from the total score of the perceived benefit of the exercise practice.
The maximum score can be taken from the scale is 20 and the minimum score is -20.
The negative result indicates that in the exercise decisional balance, the perceived harmfulness is dominant and the positive result indicates that the perceived benefit of exercise practice is dominant on the scale.
|
Change from Baseline at 9 months
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
25. oktober 2015
Primær færdiggørelse (Faktiske)
30. november 2016
Studieafslutning (Faktiske)
30. november 2016
Datoer for studieregistrering
Først indsendt
9. april 2018
Først indsendt, der opfyldte QC-kriterier
24. april 2018
Først opslået (Faktiske)
7. maj 2018
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
7. maj 2018
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
24. april 2018
Sidst verificeret
1. april 2018
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- MunzurU
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .